Try our Advanced Search for more refined results
Intellectual Property UK
-
December 02, 2025
SEP Owner Wins OK To Forge Ahead With Vivo FRAND Claim
Sun Patent Trust has asked the Unified Patent Court to determine a FRAND rate for its wireless device patents in a claim with Chinese smartphone company Vivo, according to a newly public order from the appeals court.
-
December 02, 2025
Camper Footwear Brand Wins TM Battle At EUIPO
Spanish shoe retailer Camper has persuaded European Union officials to block a Chinese company's "NuCamper" trademark application, proving that shoppers could muddle up the two brands.
-
December 02, 2025
Disney Beats Designer's Bid For 'Mickey Is Free!' TM
A Norwegian designer has failed to convince European officials that he should be able to sell streetwear stamped with the trademark "Mickey is Free!" — even with a disclaimer saying it had "nada, niente" to do with the Disney character.
-
December 02, 2025
US Musicians And Actors Say UK Breached Royalties Treaties
Trade unions representing U.S. actors and musicians urged a London court Tuesday to reverse secondary legislation that altered U.K. copyright law, saying it had unlawfully breached international treaties governing royalty payments for audio recordings.
-
December 02, 2025
Gola Trainers Owner Sues Clarks Over Stripe Design
The owner of the classic Gola trainer has accused Clarks of selling shoes that copy a specific protected stripe logo on its side, which it said was confusing shoppers and leading them to buy the rival footwear.
-
December 01, 2025
HP Gets Early Ink Cartridge Injunction At UPC
American computer giant HP has convinced the Unified Patent Court to bar a Chinese rival from selling ink cartridges that infringe its patents, marking the latest preliminary injunction involving those patents that the court has handed down.
-
December 01, 2025
Record Label Sues Partner Over £4M Royalty Dispute
A specialist record label has accused two music promotion companies of failing to pay almost £4 million ($5 million) in license fees and other royalties, asking a London judge to stop the former business partners from further infringing its IP.
-
December 01, 2025
Takeda Defends UK Patent Protection For ADHD Drug Elvanse
Takeda has swung back after a German rival asked a London court to call time on its extended patent protections for the ADHD treatment Elvanse, arguing that its U.K. supplementary protection certificate covering the drug is valid.
-
December 01, 2025
EU Launches IP Protections For Regional Crafts
The European Union launched a dedicated system on Monday to protect the names of craft and industrial products whose characteristics can be attributed to their geographic origin, in a longstanding effort to boost intellectual property protections for regionally produced artisanal products.
-
December 01, 2025
EU Blocks 'European Basketball League' TM
A U.S. company has failed to net a "European Basketball League" trademark in the European Union, giving up on its challenge against an earlier ruling that the sign lacks any distinctive character.
-
November 28, 2025
Regeneron Claims Biocon Drug Mimics Its Patented Medicine
Regeneron Pharmaceuticals has countersued Biocon to block it from infringing on its patents upholding its medication to treat macular degeneration, denying that the Indian pharmaceutical group's formulation would not infringe on its intellectual property in the U.K.
-
November 28, 2025
Building Cladding Co. Hits Back At Bid To Nix Fire Safety IP
A building facade supplier has asserted that a cladding specialist is infringing its patent and design rights, pointing out that the rival's director had toured its factory years ago and received a demonstration of the products he later copied.
-
November 28, 2025
Loft Supplies Co. Takes Aim At Rival's UK Patents
A loft supplies company has denied infringing a rival's flooring system patents, telling a London court that the U.K. registrations are not valid because they contain nothing inventive.
-
November 28, 2025
Financial Analysts' Body Suffers Blow In Fight Over 'CEFA' TM
The European Federation of Financial Analysts Societies has lost its bid to register a trademark for "CEFA EFFAS Certified European Financial Analyst" as a European court ruled that examiners had correctly found it was too similar to an existing sign.
-
November 28, 2025
UK Litigation Roundup: Here's What You Missed In London
This past week in London has seen the National Crime Agency target an Azerbaijan politician and a subsidiary of Withers over a disputed £50 million ($66 million) property portfolio, the eldest son of a British aristocratic family challenge the trustees of their multimillion-pound estate, and a sports lawyer suspected of dishonesty face action by the Solicitors Regulation Authority following his firm's closure.
-
November 28, 2025
French Clothing Biz Wins 'Sol' TM Battle At UKIPO
A French clothing company has persuaded U.K. officials to block a British opponent's "Sol Sleep" and "Sol Beach" trademark applications, proving that shoppers could mix up the brand with its earlier "SOL'S" registration.
-
November 27, 2025
Merz Loses Bid To Block Viatris In Unified Patent Court
Merz has failed to persuade the Unified Patent Court to order a preliminary injunction barring rival Viatris Santé from infringing its supplementary patent protections for its multiple sclerosis treatment, marking the first time the court has considered an injunction application for supplementary protections.
-
November 27, 2025
Gorgon Music Hits Back Over Bunny Lee Reggae Catalog
Gorgon Music has asserted that two subsidiaries of German media giant BMG failed to promote the music of dead reggae producer Bunny "Striker" Lee and therefore breached their licensing deals, meaning they were no longer enforceable.
-
November 27, 2025
Nuclear Energy Biz Can't Use 'Smartfuel' TM In EU
A nuclear energy company has lost its attempt to secure a "Smartfuel" trademark in the European Union, failing to prove that the sign isn't descriptive of all the goods it would appear on.
-
November 27, 2025
Amgen Wins UPC Appeal To Revive Cholesterol Drug Patent
Amgen has persuaded an appeals panel at the Unified Patent Court to restore its patent for cholesterol-lowering drug Repatha, overturning a previous victory for rival drugmakers Sanofi and Regeneron.
-
November 27, 2025
US Designer Sues Furniture Village Over 'Alaska' Line Theft
A furniture designer has accused a manufacturer of commissioning a series of designs and then stealing them, arguing that significant features of its protected "Alaska" concept range could be seen in the U.K. company's products.
-
November 27, 2025
AbbVie Unit Fails To Revive Dermal Filler Patent On Appeal
A European appeals panel has rejected an AbbVie subsidiary's quest to restore a dermal filler patent following a challenge from a German rival, saying that the contents of the blueprint are unnecessarily broad.
-
November 26, 2025
Judges Spare Edwards Heart Valve Protections In UPC Appeal
Edwards Lifesciences has convinced judges at the Unified Patent Court's appeals body to spare amended patent protections underpinning its heart valve technology, in a judgment that sees judges clarify the European patent court's approach to analyzing whether a patent is inventive.
-
November 26, 2025
Boots Denies Copying Travel Products Co.'s Pillow Design
Boots has pushed back against claims that it is infringing a design for a travel pillow, arguing that any elements it was accused of poaching were actually common design features used by all to ensure that the product functions.
-
November 26, 2025
Prada's Miu Miu Beats Beauty Co.'s 'Fiu Fiu' TM
Prada has succeeded in blocking a Polish beauty company's attempt to register the name "Fiu Fiu Beauty Concept" as a European trademark, after officials ruled the branding was too close to the luxury fashion group's "Miu Miu" label.
Expert Analysis
-
Considering The Status Of The US Doctrine Of Patent Misuse
A recent Ninth Circuit decision and a U.K. Court of Appeal decision demonstrate the impact that the U.S. Supreme Court's 2015 decision in Kimble v. Marvel Entertainment has had on the principle that post-patent-expiration royalty payments amount to patent misuse, not only in the U.S. but in English courts as well, say attorneys at Covington.
-
Sky Trademark Ruling Suggests Strategy Tips For Brands
Following the U.K. Supreme Court's SkyKick v. Sky trademark ruling, brand owners should strike a balance between a specification broad enough to meet business requirements but not so broad as to invite unnecessary counterattacks for bad faith, says Josh Charalambous at RPC.
-
Keeping Up With Europe's Pregrant Description Amendments
A recent Technical Board of Appeal decision that there is no legal basis in the European Patent Convention for requiring pregrant description amendments has generated legal uncertainty on this issue, and practitioners should consider deleting unclaimed alternatives, say attorneys at Finnegan.
-
How The UPC, ITC Complement Each Other In Patent Law
Attorneys at Ropes & Gray discuss the similarities and differences between the Unified Patent Court and the International Trade Commission, as well as recent matters litigated in both venues and why parties choose to file at these forums.
-
Rowing Machine IP Loss Waters Down Design Protections
The Intellectual Property Enterprise Court's recent judgment dismissing WaterRower's claim that its wooden rowing machines were works of artistic craftsmanship highlights divergence between U.K. and European Union copyright law, and signals a more stringent approach to protecting designs in a post-Brexit U.K., say lawyers at Finnegan.
-
Takeaways From EU's Draft AI Code Of Practice
The European Union AI Office’s recently published first draft of the General-Purpose AI Code of Practice sheds some welcome light on which Artificial Intelligence Act compliance issues the office finds particularly knotty and, importantly, acknowledges where further guidance will be necessary, say lawyers at Akin.
-
The Rising Tide Of EU Antitrust Enforcement In Pharma
The European Commission’s recent record-breaking €463 million fine of Teva for abusing its dominant position confirms that European Union competition law enforcement in the pharmaceutical sector remains a priority, with infringements drawing serious financial exposure, say lawyers at Cooley.
-
What The Future Of AI In Financial Services Looks Like
Artificial intelligence is rapidly transforming the global financial services industry, with a hybrid model likely to evolve where AI handles routine tasks and humans focus on strategy and decision-making, so financial institutions should work with regulators to establish ethical standards and meet regulatory expectations without stifling innovation, say lawyers at Womble Bond.
-
The EU Design System Changes US Cos. Need To Know About
With a number of major reforms to the European Union's design protection system set to take effect in the first half of 2025, U.S. companies need to stay informed about specific details to maintain effective intellectual property management in the EU market, say lawyers at Finnegan.
-
What New Int'l Treaty Means For Global AI Regulation
Lawyers at Bird & Bird consider how global artificial intelligence regulation will be affected by the first international AI treaty recently signed by the U.S., EU and U.K., as well as its implications for business and several issues that stakeholders should be aware of.
-
HMRC Transfer Pricing Guide A Vital Resource For Businesses
HM Revenue & Customs' recent guidelines on common transfer pricing compliance risks should be required reading for affected businesses in indicating HMRC's expected benchmark for documents and policies, say Tomoko Ikawa and Kapisha Vyas at Simmons & Simmons.
-
Comparing Apples To Oranges In EPO Claim Interpretation
A referral before the Enlarged Board of Appeal could fundamentally change the role that descriptions play in claims interpretation at the European Patent Office, altering best drafting practices for patent applications construed there, say lawyers at Finnegan.
-
Why India May Become A Major Patent Litigation Forum
India is reinventing itself with the goal of becoming a global hot spot for patent litigation, with recent developments at the Delhi High Court creating incentives for plaintiffs to assert patent rights in India, say Ranganath Sudarshan at Covington and IP litigator Udit Sood.
-
Takeaways From UPC's Amgen Patent Invalidity Analysis
The Unified Patent Court Central Division's decision in Regeneron v. Amgen to revoke a patent for lack of inventive step is particularly clear in its reasoning and highlights the risks to patentees of the new court's central revocation powers, say Jane Evenson and Caitlin Heard at CMS.
-
UK Approach To AI Patentability Appears Settled For Now
After a High Court ruling upended the status quo last year, the Court of Appeal’s recent decision that Emotional Perception’s artificial neural network is not patentable represents a return to the U.K.’s familiar, albeit often complex, approach to patentability of artificial intelligence technology and computer programs generally, say lawyers at Potter Clarkson.